{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:30:51Z","timestamp":1790951451213,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support","award":["20152235"],"award-info":[{"award-number":["20152235"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DA027195-01A2"],"award-info":[{"award-number":["1R01DA027195-01A2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0197-3","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T16:28:03Z","timestamp":1509640083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhi-Bin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ning","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"key":"197_CR1","first-page":"343","volume":"172","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis c infection. World Health Organ. 2014;172:343\u20136.","journal-title":"World Health Organ"},{"key":"197_CR2","first-page":"194","volume":"1","author":"YD Chen","year":"2002","unstructured":"Chen YD, Liu MY, Yu WL, et al. Hepatitis C virus infections and genotypes. HBPD Int. 2002;1:194\u2013201.","journal-title":"HBPD Int"},{"key":"197_CR3","volume-title":"China drug report 2015","author":"China National Narcotics Control Commission","year":"2015","unstructured":"China National Narcotics Control Commission. China drug report 2015. Beijing: NNCC; 2015."},{"issue":"2","key":"197_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jsat.2004.12.004","volume":"28","author":"AY Walley","year":"2005","unstructured":"Walley AY, White MC, Kushel MB, Song YS, Tulsky JP. Knowledge of an interest in hepatitis C treatment at a methadone clinic. J Subst Abus Treat. 2005;28(2):181\u20137.","journal-title":"J Subst Abus Treat"},{"issue":"Suppl 5","key":"197_CR5","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1086\/427446","volume":"40","author":"A Doab","year":"2005","unstructured":"Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis. 2005;40(Suppl 5):S313\u201320.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"197_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.07.002","volume":"77","author":"MA Stoove","year":"2005","unstructured":"Stoove MA, Gifford SM, Dore GJ. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug Alcohol Depend. 2005;77(1):81\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"197_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/pubmed\/fdr098","volume":"34","author":"Y Hser","year":"2012","unstructured":"Hser Y, Du J, Li J, et al. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. J Public Health (Oxf). 2012;34(1):24\u201331.","journal-title":"J Public Health (Oxf)"},{"issue":"3","key":"197_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/00952990.2011.643974","volume":"38","author":"J Du","year":"2012","unstructured":"Du J, Wang Z, Xie B, et al. Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China. Am J Drug Alcohol Abuse. 2012;38(3):228\u201332.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"197_CR9","volume-title":"HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in china: a meta-analysis","author":"YX Liang","year":"2013","unstructured":"Liang YX. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in china: a meta-analysis. Nantong: Nantong univ; 2013."},{"issue":"Suppl. 8","key":"197_CR10","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/01.aids.0000304706.79541.ef","volume":"21","author":"ZY Wu","year":"2007","unstructured":"Wu ZY, Luo W, Sullivan S, et al. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS. 2007;21(Suppl. 8):S115\u201322.","journal-title":"AIDS"},{"issue":"4","key":"197_CR11","first-page":"28","volume":"3","author":"HZ Qian","year":"2006","unstructured":"Qian HZ, Joseph ES, Hury TC, et al. Injection drug use and HIV\/AIDS in China: review of current situation, prevention and policy implication. Harm Reduct J. 2006;3(4):28\u201342.","journal-title":"Harm Reduct J"},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00002030-199102000-00008","volume":"5","author":"S Darke","year":"1991","unstructured":"Darke S, Hall W, Heather N, et al. The reliability and validity of a scale to measure HIV risk taking behavior among intravenous drug users. AIDS. 1991;5:181\u20135.21.","journal-title":"AIDS"},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0149-7189(94)90035-3","volume":"17","author":"NL Weatherby","year":"1994","unstructured":"Weatherby NL, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann. 1994;17:347\u201355.22.","journal-title":"Eval Program Plann"},{"issue":"4","key":"197_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1037\/0893-164X.9.4.242","volume":"9","author":"R Needle","year":"1995","unstructured":"Needle R, Fisher DG, Weatherby N, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9(4):242\u201350.","journal-title":"Psychol Addict Behav"},{"issue":"2","key":"197_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2190\/3EMQ-N350-W4XN-WT1X","volume":"36","author":"SM Strauss","year":"2006","unstructured":"Strauss SM, Astone-Twerell JM, Munoz-Plaza C, et al. Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ. 2006;36(2):141\u201358.","journal-title":"J Drug Educ"},{"issue":"6","key":"197_CR16","first-page":"495","volume":"18","author":"DU Jiang","year":"2009","unstructured":"Jiang DU, Zhen W, Zhang H, et al. HCV knowledge and HCV infection among drug users treated in a methadone maintenance treatment clinic. Chin J Drug Depend. 2009;18(6):495\u20139.","journal-title":"Chin J Drug Depend"},{"issue":"3","key":"197_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0022042613511438","volume":"44","author":"YJ Chang","year":"2014","unstructured":"Chang YJ, Hsieh J, Peng CY, et al. HIV and HCV serostatus and knowledge among patients in urban versus rural methadone maintenance clinics in Kunming. J Drug Issues. 2014;44(3):281\u201390.","journal-title":"J Drug Issues"},{"key":"197_CR18","volume-title":"The alcohol use disorders identification test. Guidelines for use in primary care","author":"World Health Organization","year":"2001","unstructured":"World Health Organization. The alcohol use disorders identification test. Guidelines for use in primary care. Geneva: World Health Organization; 2001."},{"issue":"1","key":"197_CR19","first-page":"22","volume":"17","author":"B Li","year":"2003","unstructured":"Li B, Shen YC, Zhang BQ, et al. The test of audit in China. Chin Ment Health J. 2003;17(1):22\u20134.","journal-title":"Chin Ment Health J"},{"key":"197_CR20","volume-title":"Handbook of mental health assessment scale (Revised Edition) (1999)","author":"XD Wang","year":"2009","unstructured":"Wang XD, Wang XL, Ma H, et al. Handbook of mental health assessment scale (Revised Edition) (1999). Beijing: Chinese Mental Health Journal; 2009."},{"key":"197_CR21","unstructured":"Strauss S M, Astone-Twerell J, Munoz-Plaza C E, et al. (2007) Drug treatment program patients\u2019 hepatitis C virus (HCV) education needs and their use of available HCV education services [J] BMC Health Serv Res. 7:39."},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","volume":"18","author":"GS Birkhead","year":"2007","unstructured":"Birkhead GS, Klein SJ. Integrating multiple programmer and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy. 2007;18:417\u201325.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-017-0197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:07:17Z","timestamp":1589540837000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0197-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Biographical notes of the first authors: Zhi-Bin LI, female, born in 1986, M.D., majoring in drug abuse treatment. Lei ZHANG, female, born in 1991, Master of Psychology, majoring in Social Psychology and Mental Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The research protocol was approved by the Ethics Committee of the Shanghai Mental Health Center, and each subject signed the informed consent form approved by the IRB at the Shanghai Mental Health Center. Board Name: IRB00002733-SHANGHAI MENTAL HEALTH CTR 2RB. The committee\u2019s reference number was NO. 2012-56C2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed consent forms.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"71"}}